Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest Pharmaceuticals

13 Aug, 2018, 08:09 BST Cantargia Presents Update on the CANFOUR Clinical Trial and Phase IIa Preparations

- 15 patients treated and CAN04 showed a good safety profile - A few more patients to be included to establish maximum tolerated or recommended...


10 Aug, 2018, 13:30 BST Protein Binding Assays Market Worth $425.7 Million in 2023

According to a new market research report 'Protein Binding Assays Market by Technology (Equilibrium Dialysis, Ultrafiltration,...


10 Aug, 2018, 12:00 BST Astellas Announces Acquisition of Quethera

Acquisition furthers Astellas' commitment to innovation in ophthalmology with addition of novel gene therapy program for glaucoma Astellas...


10 Aug, 2018, 11:30 BST Global Medical Nutrition Market Revenue Expected to Increase to US$ 51,311.1 Mn by 2026: Transparency Market Research

Transparency Market Research (TMR) delivers key insights on the global Medical Nutrition market in its upcoming outlook titled, "Medical...


10 Aug, 2018, 10:30 BST TNF Inhibitors Market is Anticipated to Reach US$ 53,745.37 Mn by 2026, Says TMR

The global TNF inhibitors market was valued around US$ 40,369.8 Mn in 2017. It is anticipated to expand at a stable CAGR of 2.54% during the...


10 Aug, 2018, 07:10 BST Artios Pharma Announces $84 Million (£65 Million) Series B Financing

Financing Round Led by New Investors Andera Partners and LSP Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company...


10 Aug, 2018, 02:32 BST JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Trastuzumab Biosimilar to Treat Breast Cancer

JHL Biotech has announced it received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European...


10 Aug, 2018, 02:24 BST JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer

JHL Biotech has announced it received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European...


09 Aug, 2018, 19:54 BST InDex Pharmaceuticals Updates Timeline for Top Line Results from the CONDUCT Study to First Half of 2019

InDex Pharmaceuticals Holding AB (publ) today announced an updated timeline for patient recruitment in the ongoing phase IIb study CONDUCT with the...


09 Aug, 2018, 16:14 BST Gerald Schneider joins CRB Group GmbH as managing director

Gerald Schneider, a long-time business leader in the life science and advanced technology industries, has joined CRB Group GmbH as the managing...


09 Aug, 2018, 14:15 BST NCCN Publishes First-Ever U.S. Guidelines for Rare Cancers Associated with Pregnancy

New NCCN Guidelines for gestational trophoblastic neoplasia created to ensure pregnant women with cancer receive life-saving treatment while...


09 Aug, 2018, 13:10 BST Drug Discovery Outsourcing Market Worth $4.4 Billion by 2025: Grand View Research, Inc.

The global drug discovery outsourcing market size is expected to reach USD 4.44 billion by 2025 at an 8.14% CAGR, according to a new report by...


09 Aug, 2018, 08:00 BST Eyevensys Appoints New Board Member, Gerald Cagle

Eyevensys, a clinical stage biotech company developing non-viral gene therapies for ophthalmic diseases, today announced that Gerald (Jerry)...


09 Aug, 2018, 07:42 BST Immunovia`s Blood-based IMMray™ Biomarker Array Provides Highly Accurate Diagnosis of non-small Cell Lung Cancer in a New Collaborative Study

Immunovia AB announced today that in a new collaborative study with a major global pharma company, Immunovia ́s innovative blood-based testing...


09 Aug, 2018, 00:13 BST CORRECTION - CannTrust Holdings Inc.: CannTrust and Apotex Accelerate Partnership to Fuel Global Expansion in Medical Cannabis Market

Research and Development will also Lead Product Innovation in Recreational Market CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX:...


08 Aug, 2018, 17:38 BST Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome

- Poteligeo has been approved for the treatment of the two most common types of Cutaneous T-cell lymphoma (CTCL) in previously...


08 Aug, 2018, 13:30 BST Specific Therapeutic Benefits of Cannabidiol (CBD) Validated by FDA

CannabisNewsWire Editorial Coverage In a landmark announcement, the U.S. Food and Drug Administration (FDA) recently approved a drug derived...


08 Aug, 2018, 12:00 BST Endo Reports Second-Quarter 2018 Financial Results

- Second-quarter 2018 revenues of $715 million compared to second-quarter 2017 revenues of $876 million - Second-quarter 2018...


08 Aug, 2018, 08:09 BST Eurocine Vaccines´ Nasal Influenza Vaccine Candidate Immunose™ FLU Showed Good Safety in Older Adults

Eurocine Vaccines today announced good safety and tolerability in older adults, in the second clinical phase I/II study including their...


08 Aug, 2018, 06:58 BST Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2018 Results Presentation and Webcast

Nordic Nanovector ASA (OSE: NANO) announces its second quarter and first half 2018 results on Wednesday, 22 August 2018. Second Quarter and First...


07 Aug, 2018, 21:05 BST Jazz Pharmaceuticals Announces Second Quarter 2018 Financial Results

GAAP Diluted EPS of $1.50; Adjusted Diluted EPS of $3.49 Reflects Growth of 36% Total Revenues of $500 Million, an Increase of 27% Xyrem Product...


07 Aug, 2018, 19:09 BST BioArctic Obtains Exclusive Rights to Develop Antibody Treatments for Alzheimer's Disease from a Research Project Jointly Owned with Eisai

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) has in collaboration with Eisai identified a completely new biological target, which provides an...


07 Aug, 2018, 15:30 BST Influenza Vaccine Market to Reach USD 11.4 Billion by 2025

The report, "Influenza Vaccine Market by Age Group (Pediatrics and Adults), Vaccine Type (Quadrivalent, Trivalent, and High-Dose), and Virus Type...


07 Aug, 2018, 15:30 BST Microarray Analysis Market Worth $5.52 Billion by 2023

According to a new market research report "Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services),...


07 Aug, 2018, 15:20 BST Collaborative Drug Discovery, Inc. Announces Distribution Agreement With Zastra Innovations Pvt. Ltd. in India

Zastra Innovations to distribute CDD Vault, a chemistry and biology data management platform for drug discovery. Collaborative Drug Discovery,...